Ligand validation:6BEF

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BEF_EDO_A_605	32%	80%	0.182	0.856	0.55	0.31	-	-	0	0	100%	1
6BEF_EDO_B_602	27%	80%	0.307	0.957	0.6	0.26	-	-	0	0	100%	1
6BEF_EDO_B_603	23%	81%	0.226	0.846	0.61	0.23	-	-	0	0	100%	1
6BEF_EDO_A_604	17%	84%	0.294	0.871	0.63	0.15	-	-	2	0	100%	1
6BEF_EDO_C_606	7%	87%	0.315	0.774	0.62	0.08	-	-	1	0	100%	1
6BEF_EDO_C_607	6%	79%	0.301	0.734	0.64	0.23	-	-	0	0	100%	1
6BEB_EDO_C_608	45%	80%	0.176	0.907	0.58	0.28	-	-	1	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.